In spite of a stable decline in the incidence of tuberculosis in countries participating in control surveys, there were an estimated 8.8 million new cases and 1.6 million deaths in 2005 (28). The treatment of Mycobacterium tuberculosis infections requires at least 6 months of antimycobacterial therapy with the use of multiple drugs. This long duration of treatment is justified by the poor efficacy of available antibiotics, including the main drugs isoniazid and rifampin, against the dormant M. tuberculosis bacilli (10, 26) that are thought to persist in particular environments such as the granuloma or caseum (6, 21) . In vitro models that mimic the persistent state have been developed based on nutrient starvation (4, 12), oxygen deprivation (25), and exposure to nitric oxide (23). These models showed that nonreplicative and low metabolic states of the bacteria could be responsible for the poor in vivo response to currently available drugs. The adaptive response of M. tuberculosis during the transition from aerobic growth to stationary phase results in the activation of a "dormancy" regulon (4, 22, 24). The regulon includes genes that are likely to play an essential role in the long-term survival of the bacteria and therefore encode potential targets for the development of sterilizing drugs.
Our understanding of the mechanisms used by
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The "dormancy" regulon of M. tuberculosis was not previously reported to include genes involved in peptidoglycan metabolism, although changes in the structure of this cell wall polymer are known to be associated with the transition to the stationary phase in other bacteria. In Escherichia coli, the transition is associated with an increase (1.8 to 5%) in the content of 333 cross-links to the detriment of the classical 433 crosslinks formed by the D,D-transpeptidase activity of penicillinbinding proteins (PBPs) (Fig. 1) (11) . We have previously identified the L,D-transpeptidases (Ldt) that catalyze the formation of 333 peptidoglycan cross-links as members of a novel family of active-site cysteine peptidases that have various cellular functions (5, 14, 15, 18) . In E. coli, these functions include the anchoring of a lipoprotein to the peptidoglycan in addition to the formation of 333 cross-links (14, 15) . In a mutant of Enterococcus faecium, an L,D-transpeptidase (Ldt fm ) is the key enzyme of an adaptive response to ␤-lactam antibiotics since it bypasses the D,D-transpeptidase activity of PBPs, leading to high-level resistance to the drugs (18, 20) .
Examination of the microarray data published by Betts et al. showed that an M. tuberculosis gene encoding a member of the active-site cysteine peptidase family, referred to as Rv0116c, of unknown function, was upregulated 17-fold under nutrient starvation (4) . We have therefore investigated here the structure of peptidoglycan from M. tuberculosis to evaluate whether formation of 333 peptidoglycan cross-links could be part of the adaptive response to the stationary phase. We have also produced a soluble form of the Rv0116c gene product in E. coli to analyze the catalytic activity of the purified protein and its interaction with ␤-lactam antibiotics.
MATERIALS AND METHODS
Growth conditions, purification, and peptidoglycan structure analysis. M. tuberculosis H37Rv was grown at 37°C without shaking in Dubos broth (Difco) supplemented with 10% (vol/vol) of OADC medium (Becton Dickinson), which contains oleic acid, bovine serum albumin, fraction V-glucose, and catalase. A 10-day preculture of 25 ml was used to inoculate 250 ml of the growth medium. After 3 weeks of incubation, bacteria were collected by centrifugation, resuspended in 25 ml of 10 mM phosphate buffer (pH 7.0), and inactivated by heat (96°C for 30 min). A second inactivation step was performed by adding 8% (vol/vol) sodium dodecyl sulfate, followed by incubation for 30 min at 96°C. Bacteria were collected by centrifugation and disrupted with glass beads (150 to 212 m; 5 g/5 ml [wt/vol]) for 16 h at 4°C in a cell disintegrator (The Mickle Laboratory Engineering Co., Gromshall, United Kingdom). The peptidoglycan was collected by centrifugation (15,000 ϫ g for 15 min at 4°C), extracted with 8% boiling sodium dodecyl sulfate, and washed three times with water. The peptidoglycan was treated with proteases and digested with mutanolysin and lysozyme, as previously described for purification of the peptidoglycan from enterococci (2). The resulting muropeptides were treated with ammonium hydroxide to cleave the ether link internal to MurNAc (2) or with sodium borohydride to reduce MurNAc into muramitol (20) . Peptidoglycan fragments were purified by reversed-phase high-pressure liquid chromatography (rp-HPLC) and analyzed by mass spectrometry (2) .
Production and purification of recombinant Ldt Mt1 . A portion of the ldt Mt1 gene, previously designated Rv0116C (http://www.ncbi.nlm.nih.gov/), was amplified with primers 5Ј-TTCCATGGCGCCACTCCAACCGATCC-3Ј and 5Ј-TT GGATCCGCCGACCACCTCAATGGGA-3Ј. The PCR product was digested with NcoI plus BamHI (underlined) and cloned into pET2818 (18) . The resulting plasmid encoded a fusion protein consisting of a methionine specified by the ATG initiation codon of pET2818, residues 32 to 251 of Ldt Mt1 , and a C-terminal polyhistidine tag with the sequence GSH 6 . E. coli BL21(DE3) harboring pREP4GroESL (1) and pET2818⍀ldt Mt1 was grown at 37°C to an optical density at 600 nm of 0.6 in three liters of brain heart infusion broth containing ampicillin (150 g/ml). IPTG (isopropyl-␤-D-thiogalactopyranoside) was added to a final concentration of 0.5 mM, and incubation was continued for 17 h at 16°C. Ldt Mt1 was purified from a clarified lysate by affinity chromatography on Ni 2ϩ -nitrilotriacetate-agarose resin (Qiagen GmbH, Hilden, Germany), followed by anionexchange chromatography (MonoQ HR5/5; Amersham Pharmacia Biotech) with an NaCl gradient in 50 mM Tris-HCl (pH 8.5 ). An additional size-exclusion chromatography was performed on a Superdex HR10/30 column (Amersham Pharmacia Biotech) equilibrated with 50 mM Tris-HCl (pH 7.5) containing 300 mM NaCl at a flow rate of 0.5 ml/min. The protein was concentrated by ultrafiltration (Amicon Ultra-4 centrifugal filter devices; Millipore) and stored at Ϫ20°C in the same buffer supplemented with 20% glycerol.
was purified from C. jeikeium strain CIP103337, and the concentration was determined by amino acid analysis after acid hydrolysis (2, 3) . In vitro formation of muropeptide dimers was tested in 10 l of 50 mM Tris-HCl (pH 7.5) containing 300 mM NaCl, 11 M Ldt Mt1 , and 280 M disaccharide-tetrapeptide. The reaction mixture was incubated for 2 h at 37°C and treated with ammonium hydroxide, and the resulting lactoyl-peptides were analyzed by nanoelectrospray tandem mass spectrometry using N 2 as the collision gas (2) .
Inhibition of Ldt Mt1 by ␤-lactams. Ldt Mt1 (12.5 M) was preincubated for 20 min at 37°C with ampicillin (Bristol-Myers), ceftriaxone (Roche Applied Science), and imipenem (Merck Sharpe and Dhome-Chibret) in 50 mM Tris-HCl (pH 7.5) containing 300 mM NaCl (buffer A). The L,D-transpeptidation reaction was started by the addition of the disaccharide-tetrapeptide (final concentration 280 M) and allowed to proceed for 2 h at 37°C. The reaction products were detected by mass spectrometry (19) .
The formation of enzyme-drug adducts was tested by incubating Ldt Mt1 (12. was dialyzed against water for 30 min, and the average mass of proteins and protein-␤-lactam adducts was determined as described previously (19) .
RESULTS
Cross-links generated by L,D-transpeptidation are predominant in the peptidoglycan from M. tuberculosis in stationary phase after growth in rich medium. The peptidoglycan of M. tuberculosis H37Rv was analyzed by rp-HPLC ( Fig. 2A ) and mass spectrometry (Fig. 2B and C) to evaluate the contribution of D,D-and L,D-transpeptidases to the formation of cross-links.
Peptidoglycan dimers contained both mDap 3 3mDap 3 crosslinks generated by L,D-transpeptidation (Fig. 2D) and D-Ala 4 3 mDap 3 cross-links generated by D,D-transpeptidation (Fig.  2E) . A comprehensive analysis of the dimers indicated that the majority (80%) of the cross-links were generated by L,Dtranspeptidation ( Fig. 2 and data not shown) . Such a high content in 333 cross-links has never been reported in wildtype isolates of eubacteria, revealing that the L,D-transpeptidation reaction is likely to have an essential role in the adaptation of M. tuberculosis to the stationary phase. High-resolution mass spectrometry analysis of the peptidoglycan of M. tuberculosis H37Rv confirmed several features previously identified in disaccharide-peptide monomers (reference 16 and references cited herein). The stem peptide contained L-Ala at the first position and predominantly D-iGln at the second position, which was occupied to a lesser extent by D-iGlu due to the absence of amidation of the ␣-carboxylate (Fig. 2B and C) . Likewise, the ε-carboxylate of mDap at the third position was mostly amidated. Gly residues linked to the ε-amine of mDap were also detected and formed cross-bridges in muropeptide dimers. The presence of Gly has been previously reported in the peptidoglycan of M. tuberculosis, but the position of this residue was not determined (16) . D-Ala, mostly present at the fourth position, was replaced by Asn, presumably of the D configuration, in a minority of the stem peptides. Since the latter amino acid was abundant in the culture me- dium, its presence in muropeptides could result from the exchange of D-Ala with D-Asn in the peptidoglycan due to an L,D-transpeptidation reaction, as previously discussed for E. faecium (9, 18) .
In order to analyze the sugar moiety of muropeptides, peptidoglycan fragments were reduced with sodium borohydride (data not shown) in place of the ammonium hydroxide treatment. This analysis confirmed the presence of N-glycolylmuramic acid (MurNGlyc) or N-acetylmuramic acid (MurNAc) linked to N-acetylglucosamine or glucosamine (17) . Anhydro forms of disaccharide peptides were also detected, indicative of the terminal unit of the glycan chains. These forms were not modified by treatment with ammonium hydroxide (Fig. 2C) .
Ldt Mt1 catalyzes formation of 333 peptidoglycan crosslinks in vitro. Ldt Mt1 was identified as a homologue of the L,D-transpeptidase of E. faecium (Fig. 3A) that is overproduced by M. tuberculosis under nutrient starvation (4; see also the introduction). A soluble fragment of Ldt Mt1 was produced in E. coli, purified (Fig. 3B ) and tested for in vitro cross-linking activity using as the substrate the disaccharide-tetrapeptide monomer isolated from the peptidoglycan of Corynebacterium jeikeium, which has the same structure as the predominant monomer of M. tuberculosis (unpublished data). The products of the reaction were treated with ammonium hydroxide to cleave the ether link internal to MurNAc, and the resulting lactoyl-peptides were sequenced by tandem mass spectrometry. The fragmentation pattern ( Fig. 3C and D) demonstrated the in vitro formation of mDap 3 3mDap 3 cross-links by Ldt Mt1 . The formation of dimers was not observed with disaccharide-pentapeptide ending in D-Ala-D-Ala (data not shown), indicating that Ldt Mt1 catalyzes peptidoglycan cross-linking exclusively with tetrapeptide-containing donors, as previously reported for the L,D-transpeptidase from E. faecium (18) .
Inactivation of Ldt Mt1 by formation of adducts with ␤-lactams. To investigate inhibition of the L,D-transpeptidase activity of Ldt Mt1 by ␤-lactams, the formation of dimers containing mDap 3 3mDap 3 cross-links was tested in the presence of various drug concentrations (data not shown). Ldt Mt1 was not inhibited by ampicillin up to the highest tested concentration of 5.7 mM. The expanded-spectrum cephalosporin ceftriaxone was active against Ldt Mt1 , although a high drug concentration (360 M) was required for full inhibition of enzyme activity. In contrast, the carbapenem imipenem abolished formation of mDap 3 3mDap
3 cross-links at a drug to enzyme molar ratio of 5. To gain insight into the mechanism of Ldt Mt1 inhibition by ␤-lactams, binding of the drugs to the enzyme was tested by electrospray mass spectrometry. Incubation of Ldt Mt1 with imipenem resulted in the formation of an adduct with an average mass matching the addition of imipenem (Fig. 4) . Adducts matching increments of the average mass of other carbapenems, meropenem and ertapenem, were also detected (Fig. 4B) . No adduct was detected for ampicillin and ceftriaxone.
DISCUSSION
The new structure of M. tuberculosis peptidoglycan from a stationary-phase culture reported here revealed an unusually high content (80%) of 333 cross-links generated by L,Dtranspeptidation ( Fig. 1 and 2) . These cross-links are likely in participate in the adaptation to the stationary phase since the cross-links are predominantly formed by the D,D-transpeptidase activity of the PBPs during the exponential phase of growth (11, 27) . The shift from 433 to 333 cross-links may have at least two selective advantages. First, L,D-transpeptidases are the only enzymes able to catalyze the formation of new cross-links in the absence of de novo synthesis of precursors since the mature peptidoglycan is devoid of pentapeptide stems required for the D,D-transpeptidation reaction ( Fig. 1  and 2) (11) . Second, modification of the cross-links may render the peptidoglycan resistant to the hydrolytic activity of endopeptidases.
The adaptative response to the stationary phase involving formation of 333 cross-links is likely to result from increased synthesis of Ldt Mt1 (Rv0116c) since the gene encoding this enzyme is turned on 17-fold during nutrient starvation (4) and we have directly shown that the purified enzyme catalyzes peptidoglycan cross-linking in vitro (Fig. 3) . Ldt Mt1 (Rv0116c) is therefore a potential target to develop drugs against persistent M. tuberculosis. Strikingly, we have shown that the carbapenems act as a suicide substrate of Ldt Mt1 , leading to irreversible inactivation of the enzyme (Fig. 4) . Among drugs of this class of ␤-lactams, imipenem has already been shown to be a poor substrate of the ␤-lactamases produced by M. tuberculosis (7, 8, 13) . Carbapenems are therefore potentially useful adjuvant drugs for the eradication of persistent M. tuberculosis.
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